Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 6.6B | 6.6B | 6.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.4B | 2.3B | 2.2B | 2.1B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.8B | 2.4B | 2.4B | 2.1B |
Tax provision | 659M | 525M | 644M | 400M |
Net income | 2.2B | 1.9B | 1.8B | 1.7B |
Basic EPS | 2.2 | — | 1.8 | 1.8 |
Diluted EPS | 2.2 | — | 1.8 | 1.8 |
Basic average shares | 942.0M | — | 943.5M | 937.8M |
Diluted average shares | 947.3M | — | 945.8M | 939.8M |
EBITDA | — | — | — | — |
Net income from continuing op. | 2.2B | 1.9B | 1.8B | 1.7B |
Minority interests | -8M | -8M | -9M | -10M |
Preferred stock dividends | — | — | — | — |